ArticleTheranostics2024

Lutetium-177-PSMA therapy for recurrent/metastatic salivary gland cancer: a prospective pilot study.

Niels J van Ruitenbeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.